Brought to you by 
Astra gets intl. marketing rights to Vivus's impotence drug
11 Nov 1999
Executive Summary
Astra AB of Sweden will market Vivus's (therapeutic systems for impotence) Muse (alprostadil), a treatment for erectile dysfunction, in Europe, Australia, New Zealand and South and Central America.
Deal Industry
- Biotechnology
- Medical Devices
- Pharmaceuticals
-
Pharmaceuticals
- Drug Delivery
Deal Status
- Terminated
Deal Type
-
Alliance
- Co-Promotion
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Astra gets intl. marketing rights to Vivus's impotence drug
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice